2019
DOI: 10.1016/j.hrthm.2019.09.019
|View full text |Cite
|
Sign up to set email alerts
|

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
110
0
6

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 151 publications
(117 citation statements)
references
References 124 publications
(11 reference statements)
1
110
0
6
Order By: Relevance
“…The latter, along with cardiac sodium channel NAv1.5 (SCN5A), filamin C (FLNC) and desmoplakin (DSP) mutations, is associated with a more aggressive disease and an arrhythmogenic phenotype [36]. This 'arrhythmogenic DCM' can occur in up to one third of DCM patients and overlaps with the current concept of arrhythmogenic cardiomyopathy [37].…”
Section: Dilated Cardiomyopathymentioning
confidence: 90%
“…The latter, along with cardiac sodium channel NAv1.5 (SCN5A), filamin C (FLNC) and desmoplakin (DSP) mutations, is associated with a more aggressive disease and an arrhythmogenic phenotype [36]. This 'arrhythmogenic DCM' can occur in up to one third of DCM patients and overlaps with the current concept of arrhythmogenic cardiomyopathy [37].…”
Section: Dilated Cardiomyopathymentioning
confidence: 90%
“…Furthermore, a growing body of data has shown genetic and clinical overlaps between LD-ACM and a subset of dilated cardiomyopathy (DCM) (so called arrhythmogenic-DCM, a-DCM) which presents with increased arrhythmogenic risk exceeding the degree of the morphological anomalies and systolic dysfunction [ 74 , 76 , 77 , 78 ]. On the basis of these observations, an expert panel of the Heart Rhythm Society (HRS) has proposed to include a-DCM, ARVC and LD-ACM in a common nosological entity whose hallmark is the electrical instability [ 11 ]. However this classification of ACM has yet to be agreed upon by all the experts in the field.…”
Section: Genetics Clinical and Histological Hallmarksmentioning
confidence: 99%
“…Life threatening arrhythmias and sudden cardiac death (SCD) are the main clinical characteristics of ACM and often manifest in the early stages of the disease, before the occurrence of the histological abnormalities and cardiac dysfunction [ 3 , 11 ]. However, early diagnosis is challenging due to the nonspecific clinical presentation of the disease [ 3 ]; for this reason, ACM remains a leading cause of SCD, particularly in the young and athletes [ 1 , 3 , 4 , 11 , 12 ]. Presently there is no causal therapy and the main goals of treatment are to control symptoms, delay the progression toward heart failure, and to prevent SCD with implantable cardioverter defibrillators (ICDs) [ 1 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Arytmogenní kardiomyopatie je onemocnění řazené nově do široké skupiny arytmogenních kardiomyopatií, která dle doporučení Heart Rhythm Society (HRS) z roku 2019 zahrnují všechny kardiomyopatie s klinickou arytmickou prezentací. 31 Ve své klasické formě s dominantním pravostranným postižením je ARVC většinou autosomálně dominantně dědičné onemocnění s nekompletní penetrancí, jehož genetická podstata spočívá v mutaci genů pro desmosomy a jim příbuzné proteiny, které zajišťují mezibuněčná spojení. Porucha vede k postupnému nahrazování svaloviny pravé komory fi brolipomatózní tkání, která se stává arytmogenním substrátem s rizikem rozvoje fatální arytmie (obr.…”
Section: Arytmogenní Kardiomyopatie Pravé Komoryunclassified
“…3). 31,32 Prevalence ARVC je odhadována na 1 : 5 000, muži jsou postiženi třikrát častěji. V klinickém obraze dominují arytmické příznaky -palpitace, synkopy či náhlá srdeční smrt.…”
Section: Arytmogenní Kardiomyopatie Pravé Komoryunclassified